<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Ischemic injury and reperfusion increases <z:chebi fb="1" ids="18421">superoxide</z:chebi> (<z:chebi fb="38" ids="18421,29356">O2-</z:chebi>) production and reduces the ability of neurons to scavenge free radicals, leading to the release of <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Here we test whether overexpression with the use of gene therapy of the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase (Gpx), delivered before or after experimental <z:hpo ids='HP_0001297'>stroke</z:hpo>, is protective against ischemic injury </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Sixty-two rats underwent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 1 hour </plain></SENT>
<SENT sid="3" pm="."><plain>Defective <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e> <z:mp ids='MP_0001799'>viral</z:mp> vectors expressing Gpx/lacZ or lacZ alone (control) were delivered into each striatum 12 hours before or 2 or 5 hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Striatal neuron survival at 2 days was improved by 36% when Gpx was delivered 12 hours before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo>, 26% with a 2-hour delay, and 25% when delayed 5 hours </plain></SENT>
<SENT sid="5" pm="."><plain>After <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, Gpx overexpression significantly reduced cytosolic translocation of <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> and increased the proportion of Bcl-2-positive cells compared with cells transfected with control vector </plain></SENT>
<SENT sid="6" pm="."><plain>Bax and activated caspase-3, while present in control-transfected neurons after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, were rarely noted in Gpx-transfected cells </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Expression from these <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e> <z:mp ids='MP_0001799'>viral</z:mp> vectors begins 4 to 6 hours after injection, which suggests a 9- to 11-hour temporal therapeutic window for Gpx </plain></SENT>
<SENT sid="8" pm="."><plain>This is the first study to show that overexpression of Gpx with the use of gene therapy protects against experimental <z:hpo ids='HP_0001297'>stroke</z:hpo>, even with postischemic transfection, and the neuroprotective mechanism involves attenuation of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-related events </plain></SENT>
</text></document>